Summary of Chiron Real Estate, Inc. Q2 2026 Earnings Call

1Key Financial Results and Metrics

Funds from Operations (FFO): NAREIT defined FFO per share was $0.88; core FFO was $1.04 per share.

Net Debt to Adjusted EBITDA: Improved to 6.0x from 6.6x in the previous quarter.

Same-Store Cash NOI: Increased by 0.8% year-over-year, with a normalized increase of 1.7% when excluding a one-time revenue recovery from the prior year.

General and Administrative (G&A) Costs: Reported at $3.8 million, slightly down from Q1 2026.

Capital Structure: Ended the quarter with $259 million in unutilized borrowing capacity and a leverage ratio under 40%.

2Strategic Updates and Business Highlights

Portfolio Repositioning: Focus on reallocating resources towards higher-return opportunities in senior housing, with recent acquisitions including two seniors communities and a $100 million investment.

Asset Sales: Completed the sale of 7 inpatient rehab facilities generating approximately $200 million, with plans to sell additional assets, including a surgical hospital in Beaumont, Texas for $49 million.

Leadership Team Expansion: Strengthened the management team with several key hires, enhancing operational capabilities and expertise in senior housing.

Market Valuation: Management believes the market undervalues the outpatient medical portfolio and is focused on disciplined execution to improve capital allocation.

3Forward Guidance and Outlook

G&A Costs: Expected to rise temporarily due to new management hires but anticipated to stabilize as the portfolio is repositioned.

Investment Strategy: The company is prioritizing stabilized assets for acquisitions while remaining opportunistic in the outpatient medical sector.

Pipeline Development: A robust pipeline of investment opportunities is being developed, focusing on long-term earnings growth and partnerships with top operators.

4Bad News, Challenges, or Points of Concern

Increased G&A Costs: Short-term rise in G&A expenses due to new hires may impact profitability.

Market Valuation Concerns: Management acknowledges that the market may not fully recognize the value of the outpatient medical portfolio, which could affect stock performance.

Execution Risks: Transitioning the business model and executing on the new strategy presents inherent risks, particularly in a competitive real estate market.

5Notable Q&A Insights

Focus on Stabilized Assets: Management clarified that future acquisitions will lean towards stabilized assets rather than those requiring significant lease-up time.

Pipeline of Opportunities: The new team is actively developing a large pipeline of investment opportunities, with a focus on specific markets and partnerships.

Mezzanine Loans: The company views mezzanine loans as a small but strategic part of the portfolio, providing cash flow with manageable risk.

Asset Sales Strategy: Management is evaluating further asset sales to maximize value, indicating a proactive approach to capital recycling. Overall, Chiron Real Estate is making significant strides in repositioning its portfolio and enhancing its leadership team, while also navigating challenges related to market valuation and operational costs.